Metabasis Therapeutics, Inc. http://www.alacrastore.com/company-snapshot/Metabasis_Therapeutics_Inc-2554467 Monday, October 13, 2008 2:12:39 AM 2554467 Metabasis Therapeutics, Inc. en AlacraStore RSS Builder 1.0 30 http://www.alacrastore.com/storecontent/ccbn/T1896354ccbn/T1896354norm...Good day, ladies and gentlemen, and welcome to the Metabasis conference call. My name is Lakeesha and I will be your coordinator today. At this time all participants are in listen-only mode. We will be facilitating a question and answer session towards the end of this call. (OPERATOR INSTRUCTIONS). I would now like to turn the presentation over to your host for today's call, Connie Bienfait, Vice President of Investor Relations. Please proceed. ... 8/8/2008 2:06:00 PMMetabasis Therapeutics54.0000FinalMetabasis Therapeutics Q2 2008 Earnings Conference Call TranscriptMBRX4:30pm ETTranscriptT1896354Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T1857045ccbn/T1857045norm... - Collins Stewart - AnalystGood afternoon. I am Salveen Kochnover, biotech analyst here at Collins Stewart. We are pleased next to have Metabasis Therapeutics present. On behalf of Metabasis, we have the CEO, Dr. Paul Laikind. ... 7/9/2008 4:03:00 PMMetabasis Therapeutics54.0000FinalMetabasis Therapeutics at Collins Stewart 4th Annual Growth Conference TranscriptMBRX3:00pm ETTranscriptT1857045Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T1821812ccbn/T1821812norm...Good day, ladies and gentlemen, and welcome to the First Quarter #### Metabasis Therapeutics Earnings Conference Call. (OPERATOR INSTRUCTIONS) I would now like to turn the presentation over to your host for today's call, Ms. Connie Bienfait, vice president of investor relations and corporate communications. Please proceed. ... 5/2/2008 11:05:00 AMMetabasis Therapeutics54.0000FinalQ1 2008 Metabasis Therapeutics Earnings Conference Call TranscriptMBRX4:30pm ETTranscriptT1821812Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T1765005ccbn/T1765005norm... - Cowen and Company - Analyst, Moderator Good afternoon, and welcome once again to Cowen and Company's ##th Annual Health Care Conference. I'm Phil Nadeau, a biotech analyst here at Cowen, and it's my pleasure to introduce the next presenting company. That's Metabasis. We like Metabasis here at Cowen. We think that they have a really interesting drug discovery platform, and we think that they're one of the few small capitalized companies that still have what it takes to develop and discover their own drugs. So we're really glad that their CEO, Paul Laikind, could come here today to give us about a ##-minute corporate presentation. Then there'll be a breakout immediately following in the Brandeis Room. Paul?... 3/19/2008 2:05:00 AMMetabasis Therapeutics54.0000FinalMetabasis Therapeutics at Cowen and Company Health Care Conference TranscriptMBRX2:25pm ETTranscriptT1765005Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T1748833ccbn/T1748833norm...Good day, ladies and gentlemen, and welcome to the Fourth Quarter #### Metabasis Therapeutics Earnings Conference Call. At this time all participants are in a listen-only mode. We will be facilitating a question and answer session towards the end of today's conference. (OPERATOR INSTRUCTIONS) I would now turn your call over to Ms. Constance Bienfait, Vice President of Investor Relations and Corporate Communications. Please proceed. ... 3/18/2008 11:05:00 AMMetabasis Therapeutics54.0000FinalQ4 2007 Metabasis Therapeutics Earnings Conference Call TranscriptMBRX4:30pm ETTranscriptT1748833Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T1744255ccbn/T1744255norm... - Metabasis Therapeutics, Inc. - President and CEO I'm pleased to be here today to tell you about Metabasis Therapeutics. We are fairly local, a San Diego, company. We went public in ####. We are a company that are focused on small molecule therapeutics, mainly for metabolic disease. This is a very interesting time to learn about Metabasis if you don't know too much about us. We had a fairly difficult year last year on one of our products but we have a pipeline of products with four products in the clinical stage of development right now and two of those are key metabolic products targeting the largest market opportunities out there, diabetes and Hyperlipidemia and both of those are reaching critical proof of concept milestones over the next six months or so, so we're really looking forward to a very exciting ####.As a Company, we have been focused on liver and liver related diseases and this has given us a lot of opportunity. We have developed a couple of unique technologies that allow... 2/19/2008 7:24:00 PMMetabasis Therapeutics54.0000FinalMetabasis Therapeutics at Roth Capital Partners 20th Annual OC Growth Stock Conference TranscriptMBRX12:30pm PTTranscriptT1744255Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T1750145ccbn/T1750145normMetabasis Therapeutics at BIO CEO & Investor Conference2/12/2008 2:06:00 PMMetabasis Therapeutics54.0000FinalMetabasis Therapeutics at BIO CEO & Investor Conference TranscriptMBRX10:15am ETTranscriptT1750145Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T1690133ccbn/T1690133norm12/31/2007 5:21:16 PMMetabasis Therapeutics54.0000FinalMetabasis Therapeutics at Lazard Capital Markets 4th Annual Healthcare Conference TranscriptMBRX9:00am ET... - Lazard Capital Markets - Analyst, Moderator Good morning. We'd like to begin the next presentation. We're pleased to have with us this morning Metabasis. Metabasis is a biotechnology company based in California, and here to present is Paul Laikind. Dr. Laikind is the President and CEO of Metabasis. Thank you. ... TranscriptT1690133Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/ccbn/T1683580ccbn/T1683580norm11/6/2007 1:06:00 PMMetabasis Therapeutics54.0000FinalQ3 2007 Metabasis Therapeutics Earnings Conference Call TranscriptMBRX4:30pm ET...Good day, ladies and gentlemen and welcome to the Third Quarter #### Metabasis Therapeutics Conference Call. My name is [Samuel] and I'll be your coordinator for today. At this time, all participants are in a listen-only mode. We will conduct a question-and-answer session toward the end of this conference. (OPERATOR INSTRUCTIONS). As a reminder, this conference is being recorded for replay purposes. I would now like to turn the call over to today's host, Ms. Constance Bienfait, Vice President Investor Relations and Corporate Communications. Please proceed, ma'am. ... TranscriptT1683580Credit & Investment ResearchThomson StreetEventshttp://www.alacrastore.com/storecontent/srp/1087388748srp/1087388748norm...Address:#### Towne Center Drive, Building ###, San Diego, California ##### Incorporated:DelawareWeb Site: www.mbasis.comSIC Classification: Pharmaceutical Preparations (####) Business Description: Metabasis Therapeutics, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule drugs principally to treat metabolic diseases linked to pathways in the liver and to treat liver diseases. Examples of common metabolic diseases include diabetes, hyperlipidemia, a disease involving elevated levels of lipids such as cholesterol, and obesity. IPO Date: ##-##-####... 108738874859101M105MBRX10/6/2006 12:15:00 PM1087388748Credit & Investment ResearchSharkRepellent.net